Which closed-end funds own Ascendis Pharma A/S?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $14.9M. Security type: common equity. Country: Denmark. CUSIP K08588103 · ISIN DK0060615755 · ticker ASND.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| ASG Liberty All Star Growth Fund | U.S. Equity | 1.29% | $5.1M | 19,190 sh | $398M | 13.4% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.45% | $3.1M | 11,544 sh | $690M | 3.5% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.33% | $4.5M | 16,937 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| THW abrdn World Healthcare Fund | Healthcare | 0.31% | $2.1M | 8,031 sh | $689M | 4.3% discount | Jun 30, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: Ascendis Pharma A/s.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Ascendis Pharma A/s | common equity | 1 |
Issuer-level search for “ASND” → · Compare two funds’ portfolios →